GP IIb/IIIa blockade during peripheral artery interventions

CardioVascular and Interventional Radiology

Volumn 31, Issue 1, 2008, Pages 8-13

  Tepe, Gunnar ^a   Wiskirchen, Jakub ^a   Pereira, Philippe ^a   Claussen, Claus D ^a   Miller, Stephen ^a   Duda, Stephan H ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Jewish Hospital   (Germany)

Author keywords

Atherosclerosis; Endovascular; Peripheral arterial interventionary drug; Platelet

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; RETEPLASE; TICLOPIDINE; TIROFIBAN; UROKINASE;

ACUTE CORONARY SYNDROME; ADD ON THERAPY; ARTERY; ARTERY THROMBOSIS; BELOW KNEE AMPUTATION; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CORONARY ARTERY; DRUG DOSE ESCALATION; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TARGETING; GRAFT FAILURE; HUMAN; LEG EDEMA; LIMB ISCHEMIA; LOADING DRUG DOSE; MONOTHERAPY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; REVIEW; SURGICAL MORTALITY; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FIBRINOLYTIC AGENTS; HUMANS; PERIPHERAL VASCULAR DISEASES; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 38049139047     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00270-005-0266-y     Document Type: Review

References (25)

1. Ouriel K, Castaneda F, McNamara T, et al. (2004) Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: Results from the RELAX trial. J Vase Intervent Radiol 15(3):229-238
2. Yoon HC, Miller FJ (2002) Using a peptide inhibitor of the glycoprotein IIb/IIIa platelet receptor: Initial experience in patients with acute peripheral arterial occlusions. Am J Roentgentl 178(3):617-622
3. Drescher P, McGuckin J, Rilling WS, et al. (2003) Catheter-directed thrombolytic therapy in peripheral artery occlusions: Combining reteplase and abciximab. Am J Roentgenol 180(5):1385-1391
4. Tepe G, Hahn U, Pusich B, et al. (2001) New strategies in platelet inhibition in noncoronary interventions. Semin Vasc Surg 14(2):143-149
5. Ouriel K (2002) Current status of thrombolysis for peripheral arterial occlusive disease. Ann Vasc Surg 16(6):797-804
6. Cho L, Topol EJ, Balog C, et al. (2000) Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender: Pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stent. J Am Coll Cardiol 36(2):381-386
7. Lincoff AM, Tcheng JE, Califf RM, et al. (1999) Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: One-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Circulation 99(15):1951-1958
8. Moliterno DJ, Topol EJ (1997) Conjunctive use of platelet glycoprotein IIb/IIIa antagonists and thrombolytic therapy for acute myocardial infarction. Thromb Haemost 78(1):214-219
9. Connors JJ (2004) Phaniiacologic agents in stroke prevention, acute stroke therapy, and interventional procedures. J Vase Intervent Radiol 15:87-101
10. Herrmann HC, Moliterno DJ, Ohman EM, et al. (2000) Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: Results from the SPEED (GUSTO-4 Pilot) Trial. J Am Coll Cardiol 36(5):1489-1496
11. Ouriel K, Kandarpa K, Schuerr DM, et al. (1999) Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: The PURPOSE trial. J Vase Intervent Radiol 10(8):1083-1091
12. Valji K (2000) Evolving strategies for thrombolytic therapy of peripheral vascular occlusion. J Vase Intervent Radiol 11(4):411-420
13. de Lemos JA, Gibson CM, Antman EM, et al. (2001) Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial. Am Heart 141(4):592-598
14. Swischuk JL, Fox PF, Young K, et al. (2001) Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: Results and complications. J Vasc Intervent Radiol 12(4):423-430
15. Lincoff AM (2000) Potent complementary clinical benefit of abciximab and stenting during percutaneous coronary revascularization in patients with diabetes mellitus: Results of the EPISTENT trial. Am Heart J 139(2 Pt 2):S46-S52
16. ERASER Study Group (1999) Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). The ERASER Investigators. Circulation 100(8):799-806
17. Sacks D, Rundback JH, Martin LG (2000) Renal angioplasty/stent placement and hypertension in the year 2000. J Vasc Intervent Radiol 11(8):949-953
18. Marso SP, Lincoff AM, Ellis SG, et al. (1999) Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy. Circulation 100(25):2477-2484
19. Tepe G, Schott U, Erley CM, et al. (1999) Platelet glycoprotein IIb/IIIa receptor antagonist used in conjunction with thrombolysis for peripheral arterial thrombosis. Am J Roentgenol 172(5):1343-1346
20. Duda SH, Tepe G, Luz O, et al. (2001) Peripheral artery occlusion: Treatment with abciximab plus urokinase versus with urokinase alone-A randomized pilot trial (the PROMPT Study). Platelet Receptor Antibodies in Order to Manage Peripheral Artery Thrombosis. Radiology 221(3):689-696
21. Hull JE, Hull MK, Urso JA (2004) Reteplase with or without abcixiamb for peripheral arterial occulsions: Efficacy and adverse events. J Vasc Intervent Radiol 15(6):557-564
22. Ouriel K, Veith FJ, Sasahara AA (1998) A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 338(16):1105-1111
23. Hall KV (1962) The great saphenous vein used in-situ as an arterial shunt after extirpation of vein valves. Surgery 51:492-499
24. Rutherford JB (2000) Endovascular interventions in the management of chronic lower extremity ischemia. In: JB (ed.) Vascular Surgery 2000; 5th ed. WB Saunders, Philadelphia, pp. 1058-1059
25. Feiring A, Wesolowski AA, Lade S (2004) Primary stent-supported angioplasty for treatment of below-knee critcal limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol 44(12):2307-2314